Pleiotropic effects of intravascular haemolysis on vascular homeostasis.
The breakdown of senescent or defective red blood cells releases red cell contents, especially haemoglobin, which scavenges nitric oxide (NO) and decomposes to haem and free iron. These are potent oxidants, all of which have promoted the evolution of inducible and vasculoprotective compensatory pathways to rapidly clear and detoxify haemoglobin, haem and iron. Chronic haemolytic red cell disorders as diverse as sickle cell disease, thalassaemia, unstable haemoglobinopathy, cytoskeletal defects and enzymopathies have been linked to a clinical constellation of pulmonary hypertension, priapism, leg ulceration and possibly cerebrovascular disease and thrombosis. Besides free haemoglobin, haemolysis has been associated with extracellular arginase that limits substrate availability to NO synthase, endogenous inhibitors of NO synthase activity, and inappropriate activation of haemostatic pathways. This article reviews the haemolytic disorders that have been reported to manifest vascular complications, and explores the speculative possibility that haemolysis mediates some of the vascular complications of inflammation and diabetes.
Kato
Gregory J
GJ
Pulmonary and Vascular Medicine Branch, National Heart, Lung and Blood Institute and the Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892-1476, USA. gkato@mail.nih.gov <gkato@mail.nih.gov>
Taylor
James G
JG
D000755:Anemia, Sickle Cell / Q000150:complications; D003920:Diabetes Mellitus / Q000503:physiopathology; D006402:Hematologic Diseases / Q000150:complications* / Q000503:physiopathology; D006461:Hemolysis / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000150:complications; D009569:Nitric Oxide; D013789:Thalassemia / Q000150:complications; D014652:Vascular Diseases / Q000209:etiology* / Q000503:physiopathology
D009569:Nitric Oxide